Workshop program

Friday, 3.5.2024

13:00 Welcome Burkhard Tönshoff, Heidelberg
13:05 Incidence and time-varying determinants of graft failure after re-transplantation in paediatric primary kidney transplant recipients in the Eurotransplant area. Agnieszka Prytula, Gent
13:30 Prospective longitudinal multi-centre study evaluating modifiable barriers to accessing transplantation and transplant outcomes in children in Europe - the EuPAKT study. Jisoo Kim, Stephen D Marks, London
13:45 Pragmatic trials/low interventional trial/randomized registry trials (RRT) in the new EU regulation. Burkhard Tönshoff, Heidelberg
14:00 The prospective randomized SOPHOCLES trial: Stop hypertension - improving children's lives after kidney transplantation. Anette Melk, Hannover, Elke Wühl, Heidelberg
14:25 Management of children with failing kidney allografts: A retrospective and prospective multicentre analysis. Zainab Arslan, Rukshana Shroff, London
14:45 Break
15:00 Age-related efficacy and safety of tacrolimus-based immunosuppression in paediatric kidney transplantation – a benchmark study of the CERTAIN registry. Jon Jin Kim, Nottingham; Vasilis Kosmoliaptsis, NIHR British Transplant Research Unit; Irina Mohorianu, Head of Bioinformatics, Computer Science Wellcome-MRC Cambridge Stem Cell Institute, Cambridge
15:20 S3 guideline “Immunosuppressive therapy after paediatric kidney transplantation”, sponsored by the Innovation Committee at the Federal Joint Committee Germany - Interim report Lars Pape, Essen
15:40 Kidney transplantation in children and adolescents with C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN): a natural history study Christian Patry, Heidelberg
16:00 European study on the risks of SARS-CoV-2 infection in paediatric kidney transplant recipients. Camille Laroche, Vancouver, Stephen Marks, London